Gem Hopkins
Investor Relations Contact chez SILENCE THERAPEUTICS PLC
Postes actifs de Gem Hopkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SILENCE THERAPEUTICS PLC | Investor Relations Contact | 01/08/2020 | - |
| Public Communications Contact | 01/08/2020 | - |
Historique de carrière de Gem Hopkins
Anciens postes connus de Gem Hopkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Investor Relations Contact | - | 01/11/2018 |
Statistiques
Internationale
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Investor Relations Contact | 2 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Gem Hopkins
- Expérience
